Publicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (71)

2024

  1. The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells

    Gut, Vol. 73, Núm. 9, pp. 1489-1508

2023

  1. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights

    European Urology, Vol. 84, Núm. 1, pp. 127-137

2022

  1. A faecal microbiota signature with high specificity for pancreatic cancer

    Gut, Vol. 71, Núm. 7, pp. 1359-1372

  2. Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma

    Gut, Vol. 72, Núm. 2, pp. 345-359

  3. Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis

    eBioMedicine, Vol. 75

2021

  1. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

    Genome Medicine, Vol. 13, Núm. 1

  2. Correction: Earl et al. Somatic mutation profiling in the liquid biopsy and clinical analysis of hereditary and familial pancreatic cancer cases reveals kras negativity and a longer overall survival. Cancers 2021, 13, 1612

    Cancers

  3. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses

    Gut, Vol. 70, Núm. 2, pp. 319-329

  4. Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), Vol. 30, Núm. 6, pp. 423-430

  5. Somatic mutation profiling in the liquid biopsy and clinical analysis of hereditary and familial pancreatic cancer cases reveals kras negativity and a longer overall survival

    Cancers, Vol. 13, Núm. 7

2020

  1. A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants

    EBioMedicine, Vol. 53

  2. Bratislava Statement: Consensus recommendations for improving pancreatic cancer care

    ESMO Open, Vol. 5, Núm. 6

  3. Diesel exhaust and bladder cancer risk by pathologic stage and grade subtypes

    Environment International, Vol. 135

  4. Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 29, Núm. 5, pp. 1009-1018

2019

  1. Ambient air pollution and incident bladder cancer risk: Updated analysis of the Spanish Bladder Cancer Study

    International Journal of Cancer, Vol. 145, Núm. 4, pp. 894-900

  2. Author's reply to: Air pollution and incident bladder cancer: A risk assessment

    International Journal of Cancer

  3. CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis

    Bladder Cancer, Vol. 5, Núm. 2, pp. 159-169

  4. Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case–control approaches

    International Journal of Cancer, Vol. 144, Núm. 7, pp. 1540-1549

  5. Resection of pancreatic cancer in Europe and USA: An international large-scale study highlighting large variations

    Gut, Vol. 68, Núm. 1, pp. 130-139

  6. Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance

    Oncogene, Vol. 38, Núm. 27, pp. 5469-5485